title: Loss of p53 and Ink4a/Arf cooperate in a cell autonomous fashion to induce metastasis of hepatocellular carcinoma cells.
abstract: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. HCC patients frequently present with disease that has metastasized to other regions of the liver, the portal vein, lymph nodes, or lungs, leading to poor prognoses. Therefore, model systems that allow exploration of the molecular mechanisms underlying metastasis in this disease are greatly needed. We describe here a metastatic HCC model generated after the somatic introduction of the mouse polyoma virus middle T antigen to mice with liver-specific deletion of the Trp53 tumor suppressor locus and show the cell autonomous effect of p53 loss of function on HCC metastasis. We additionally find that cholangiocarcinoma also develops in these mice, and some tumors display features of both HCC and cholangiocarcinoma, suggestive of origin from liver progenitor cells. Concomitant loss of the Ink4a/Arf tumor suppressor locus accelerates tumor formation and metastasis, suggesting potential roles for the p16 and p19 tumor suppressors in this process. Significantly, tumor cell lines isolated from tumors lacking both Trp53 and Ink4a/Arf display enhanced invasion activity in vitro relative to those lacking Trp53 alone. Thus, our data illustrate a new model system amenable for the analysis of HCC metastasis.
authors: Program in Gene Function and Expression, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.
authors: Ya-Wen
authors: YW
authors: Chen
authors: David S
authors: DS
authors: Klimstra
authors: Michelle E
authors: ME
authors: Mongeau
authors: Jessica L
authors: JL
authors: Tatem
authors: Victor
authors: V
authors: Boyartchuk
authors: Brian C
authors: BC
authors: Lewis
mesh_terms: D000818:Animals; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000172:deficiency* / Q000235:genetics; D017353:Gene Deletion; D008114:Liver Neoplasms, Experimental / Q000235:genetics / Q000473:pathology*; D008175:Lung Neoplasms / Q000556:secondary*; D051379:Mice; D008822:Mice, Transgenic; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency* / Q000235:genetics
chemical_list: C417743:Cdkn2a protein, mouse; D019941:Cyclin-Dependent Kinase Inhibitor p16; D016159:Tumor Suppressor Protein p53
references: Mol Cell Biol. 1997 Sep;17(9):4967-78
references: 9271375
references: J Clin Invest. 2004 Jun;113(12):1774-83
references: 15199412
references: Virology. 1998 Sep 1;248(2):305-11
references: 9721239
references: J Biol Chem. 1999 Jan 1;274(1):305-15
references: 9867845
references: Gastroenterology. 1999 Feb;116(2):394-400
references: 9922321
references: Oncogene. 1999 Jan 21;18(3):789-95
references: 9989830
references: PLoS Biol. 2004 Nov;2(11):e332
references: 15455033
references: Cell. 2004 Dec 17;119(6):847-60
references: 15607980
references: PLoS Biol. 2005 Jan;3(1):e11
references: 15630473
references: Mol Cell Biol. 2005 Feb;25(4):1228-37
references: 15684377
references: Br J Cancer. 2005 Jan 31;92(2):252-8
references: 15668718
references: Oncogene. 2005 Feb 17;24(8):1477-80
references: 15608678
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Cell Cycle. 2005 Oct;4(10):1335-7
references: 16177571
references: Am J Pathol. 2006 Apr;168(4):1155-68
references: 16565491
references: Cell. 2006 Jun 30;125(7):1253-67
references: 16814713
references: Cancer Cell. 2006 Aug;10(2):99-111
references: 16904609
references: Nat Rev Cancer. 2006 Sep;6(9):674-87
references: 16929323
references: Cell. 2000 Jan 7;100(1):57-70
references: 10647931
references: Cancer. 2000 Jul 1;89(1):60-8
references: 10897001
references: Semin Cancer Biol. 2000 Jun;10(3):185-200
references: 10936068
references: Am J Pathol. 2000 Sep;157(3):1031-7
references: 10980141
references: J Virol. 2001 Feb;75(3):1401-7
references: 11152513
references: Nature. 2001 Mar 1;410(6824):50-6
references: 11242036
references: J Biol Chem. 2001 Apr 27;276(17):13989-94
references: 11278564
references: Nature. 2001 Sep 6;413(6851):83-6
references: 11544530
references: Oncogene. 2001 Oct 25;20(48):7104-9
references: 11704835
references: Nat Genet. 2001 Dec;29(4):418-25
references: 11694875
references: Am J Surg Pathol. 2002 Aug;26(8):989-97
references: 12170085
references: Nature. 2002 Aug 22;418(6900):823
references: 12192390
references: Curr Opin Genet Dev. 2003 Feb;13(1):77-83
references: 12573439
references: Nat Med. 2003 Apr;9(4):416-23
references: 12640447
references: Clin Cancer Res. 2003 Jul;9(7):2657-64
references: 12855644
references: Genes Dev. 2003 Dec 15;17(24):3127-38
references: 14681205
references: Horm Metab Res. 2003 Nov-Dec;35(11-12):685-93
references: 14710347
references: Horm Metab Res. 2003 Nov-Dec;35(11-12):802-8
references: 14710361
references: Oncogene. 1997 Jan 30;14(4):395-404
references: 9053836
references: Nat Genet. 1995 Jan;9(1):41-7
references: 7704023
references: Curr Biol. 1994 Jan 1;4(1):1-7
references: 7922305
references: Annu Rev Med. 1994;45:297-323
references: 8198385
references: Cell. 1993 Sep 10;74(5):813-22
references: 8374952
references: Cancer Res. 1993 Apr 15;53(8):1719-23
references: 8467484
references: Nature. 1992 Mar 19;356(6366):215-21
references: 1552940
references: Cell. 1990 Jun 15;61(6):1137-46
references: 2350785
references: Lancet. 1989 Dec 2;2(8675):1338
references: 2574287
references: Oncogene. 1989 Jun;4(6):715-24
references: 2543942
references: Cancer Res. 2004 Jan 1;64(1):48-54
references: 14729607
references: Cancer Res. 2004 Feb 15;64(4):1315-22
references: 14973059
references: Virology. 1998 Sep 1;248(2):295-304
references: 9721238